- Home
- PFX vs PMVP Comparison
PFX vs PMVP Comparison
Compare PFX & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFX
- PMVP
- Stock Information
- Founded
- PFX 2010
- PMVP 2013
- Country
- PFX United States
- PMVP United States
- Employees
- PFX N/A
- PMVP N/A
- Industry
- PFX Finance: Consumer Services
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- PFX Finance
- PMVP Health Care
- Exchange
- PFX Nasdaq
- PMVP Nasdaq
- Market Cap
- PFX 96.4M
- PMVP 77.4M
- IPO Year
- PFX N/A
- PMVP 2020
- Fundamental
- Price
- PFX $48.13
- PMVP $1.24
- Analyst Decision
- PFX
- PMVP Strong Buy
- Analyst Count
- PFX 0
- PMVP 1
- Target Price
- PFX N/A
- PMVP $5.00
- AVG Volume (30 Days)
- PFX 808.0
- PMVP 2.7M
- Earning Date
- PFX 08-06-2025
- PMVP 11-06-2025
- Dividend Yield
- PFX 2.97%
- PMVP N/A
- EPS Growth
- PFX N/A
- PMVP N/A
- EPS
- PFX 3.06
- PMVP N/A
- Revenue
- PFX $23,958,590.00
- PMVP N/A
- Revenue This Year
- PFX $10.24
- PMVP N/A
- Revenue Next Year
- PFX N/A
- PMVP N/A
- P/E Ratio
- PFX $15.74
- PMVP N/A
- Revenue Growth
- PFX 7.47
- PMVP N/A
- 52 Week Low
- PFX $44.56
- PMVP $0.81
- 52 Week High
- PFX $57.40
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- PFX 42.05
- PMVP 42.89
- Support Level
- PFX $47.84
- PMVP $1.12
- Resistance Level
- PFX $48.22
- PMVP $1.35
- Average True Range (ATR)
- PFX 0.19
- PMVP 0.16
- MACD
- PFX -0.01
- PMVP -0.03
- Stochastic Oscillator
- PFX 25.11
- PMVP 16.55
About PFX PhenixFIN Corporation
PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.